🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#GoBucks

Bucks first 10 games: • -54 with Dame on • +30 with Dame off Bucks last 11 games: • +113 with Dame on • -5 with Dame off

Retweet if you love Giannis Antetokounmpo

Hello Ringer readers, listeners, and viewers! If you enjoy our work and want us to receive a fair contract before the end of February, click here to send our management a letter showing your support. actionnetwork.org/letters/suppor…

Giannis Antetokounmpo's 2023-24 regular season: ▪️30.4 PTS ▪️11.5 REB ▪️6.5 AST (career high) ▪️61.1% FG (career high) ▪️64.9% TS (career high) ▪️Career-high 10 triple doubles ▪️Bucks record for most pts in a game (64) ▪️1st player in NBA history to average 30 pts on 60% FG

#letsgobucks

Wild, but true: With Giannis and Damian Lillard out, the Bucks become the first team EVER to win a playoff game without their top-2 scorers from the regular season. H/t Matt Williams

Just over 2 weeks away from Strain for the Brain, annual run/walk to support brain tumor patients and their families as well as brain tumor research MCW Cancer Center MCW Brain & Spine Tumor Program Neurology MCW MCW Neurosurgery. Sign up today! StrainForTheBrain.org

⚡️Today FDA approved Vorasidenib for IDH-mutant low grade gliomas When patients ask you about this drug, make sure to inform them that ▶️ risk of tumor progression at 2 years is 49% with Vorasidenib (INDIGO trial) compared to 15% with chemoRT (RTOG 9802) ▶️tumors remain stable

Excited to be open to accrual! Lucky number NRG BN013 - a phase 3 randomized trial of SRS vs. FSRS for intact brain mets NRG Oncology @JYangMDPhD Martin Tom Manmeet Ahluwalia, MD, MBA, FASCO Michael Vogelbaum Mei Polley

The NRG-BN013 phase III clinical trial was recently activated as a part of the NRG Oncology brain tumor portfolio. NRG-BN013 will compare two schedules of stereotactic radiosurgery (SRS) for patients with intact brain metastases. Rupesh Kotecha Read more: ow.ly/7Paq50Tmfma

Our annual Technical and Clinical Abstract Awards will now honour two of our most dedicated colleagues. 🔬 The Technical Abstract Award is named after Prof. Jan Jacob Wouter Lagendijk 🏥 The Clinical Abstract Award is named after Dr. Christopher Schultz mrlconsortium.org

"What is 'too old' for spine SBRT re: risk of vertebral compression fracture (VCF)?" is something colleagues and I debated at tumor boards on many occasions. We now have the answer (OPEN access) IJROBP - The Red Journal Radiation Oncology arjun sahgal #radonc #SBRT sciencedirect.com/science/articl… 1/x

Our comprehensive assessment of NCI cooperative group trials is out in JNCI! If you are involved or enrolling in coop trials, please consider reading. A 🧵of our major findings. 1/12 academic.oup.com/jnci/advance-a…

💔😞 RIP, my friend Felix Feng Please consider donating to the American Cancer Society ASTRO Felix Feng MD Clinician Scientist Grant Award. Let his incredible legacy live on. donate.cancer.org/g/tjjfqwdnrxrl…

Now tell me who the real MVP is

Congratulations to Dr. William A Hall, MD on being named the next Chair for MCW Radiation Oncology! We are so fortunate to have him as our next leader. I look forward to working with him to advance Medical College of Wisconsin and MCW Cancer Center's impact in cancer care and beyond.

RT if you love Giannis Antetokounmpo.

2 years since we saw this man healthy in the playoffs. #letsgoBucks

Riegel et al. Britta L. Bureau, MD Medical College of Wisconsin analyzed real-world outcomes for newly diagnosed GBM patients treated with or without TTFields and found that TTFields improved OS and PFS, with higher device usage linked to better outcomes. #JNO Read more:link.springer.com/article/10.100…